In Response to Blood Shortages Due to COVID-19, Masimo Offers Licenses for rainbow® Noninvasive Blood Constituent Monitoring, Including Total Hemoglobin, SpHb®, at No Additional Charge Dur...
Masimo Corporation (MASI)
Last masimo corporation earnings: 4/28 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
masimo.com/about-masimo/investors
Company Research
Source: Business Wire
rainbow® Can Help Masimo Customers Better Manage Blood Supplies with SpHb® and Monitor Patients Receiving iNO Therapy with SpMet® IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that, in response to current worldwide blood shortages driven by the coronavirus pandemic, it is making rainbow® licenses available for no additional charge to hospitals where rainbow®-ready devices are already in use. The Masimo rainbow® platform allows for the noninvasive and continuous monitoring of 12 parameters, including hemoglobin (SpHb®), oxyhemoglobin (SpO2), and methemoglobin (SpMet®). Once rainbow® is enabled, hospitals can purchase RD rainbow® sensors at discounted prices during this pandemic. The program is available globally and is planned to continue until the pandemic subsides.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200323005755/en/Masimo RD rainbow SET® Sensor (Photo: Business Wire)SpHb provides real
Show less
Read more
Impact Snapshot
Event Time:
MASI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MASI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MASI alerts
High impacting Masimo Corporation news events
Weekly update
A roundup of the hottest topics
MASI
News
- MASIMO INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Masimo Corporation - MASIPR Newswire
- The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories [Yahoo! Finance]Yahoo! Finance
- Smart Pulse Oximeters Market Size Projected to Reach USD 3.6 Billion by 2032, Growing at a CAGR of 7.3% - Research by SNS Insider [Yahoo! Finance]Yahoo! Finance
- Masimo Co. (NASDAQ: MASI) had its price target raised by analysts at Piper Sandler from $180.00 to $210.00. They now have an "overweight" rating on the stock.MarketBeat
- Masimo Co. (NASDAQ: MASI) had its price target raised by analysts at Wells Fargo & Company from $171.00 to $193.00. They now have an "overweight" rating on the stock.MarketBeat
MASI
Earnings
- 11/5/24 - Beat
MASI
Sec Filings
- 12/16/24 - Form 144
- 11/18/24 - Form 8-K
- 11/18/24 - Form 8-K
- MASI's page on the SEC website